Navigation Links
Exelixis Reports XL647 Clinical Data at AACR-NCI-EORTC Conference
Date:10/24/2007

ere observed. Two events of clinically asymptomatic Grade 3 QTc prolongation occurred in two of four patients enrolled at the 350 mg dose when read by machine. On manual re-read these events were determined to be Grade 2. The dose of 300 mg was declared to be the MTD when administered daily.

The adverse event profile in phase 2 was consistent with phase 1: the most common adverse events were Grade 1 and 2 diarrhea, rash, fatigue, and nausea. Clinically asymptomatic QTc prolongation was also observed.

About the Phase 2 Trial of XL647 as First-Line Therapy

This open-label phase 2 trial is ongoing in previously untreated patients with stage IIIB or IV NSCLC who have adenocarcinoma histology and meet one of the following three criteria: Asian descent, female gender, or no or minimal smoking history. XL647 is administered orally at a dose of 350 mg on Days 1-5 of repeated 14-day cycles. The trial is designed to enrich for patients with activating mutations in the EGF receptor (EGFR) which have been associated with improved sensitivity to other EGFR inhibitors. Based on the selection criteria, Exelixis anticipates that approximately 30 percent of subjects in the trial will have activating EGFR mutations. This design should allow the accumulation of data for patients with and without EGFR mutations, helping to identify those patients most likely to benefit from treatment with XL647.

About XL647

XL647 is a potent inhibitor of receptor tyrosine kinases (RTKs) that are implicated in driving tumor cell proliferation and tumor vascularization (blood vessel formation). XL647 inhibits EGFR, HER2 and VEGFR2. The compound has been optimized for high potency and oral bioavailability, demonstrates excellent activity in target-specific cellular functional assays, and has shown sustained inhibition of target RTKs in vivo in preclinical models following a single oral dose. Two phase 2 trials in patients with NSCLC are ongoing.

About Exelixis

Exe
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Six Abstracts Featuring Exelixis Compounds Accepted At ASCO Conference
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 21, 2015  The increase of diabetes due ... for self-monitoring blood glucose (SMBG) meters and strips ... potential for this market.  Availability of inexpensive generic ... profit margins. Photo - http://photos.prnewswire.com/prnh/20150417/199443 ... & Sullivan, US Self-monitoring Blood Glucose Market ...
(Date:4/21/2015)... N.J. and PARIS and BURLINGTON, ... Quest Diagnostics (NYSE: DGX ), the ... Inserm, the French National Institute of Health and ... novel datashare initiative they co-founded to provide scientists ... access to BRCA1 and BRCA2 genetic data. The ...
(Date:4/21/2015)... 2015  GenVec, Inc. (NASDAQ: GNVC ) ... collaboration agreement with the Laboratory of Malaria Immunology ... Allergy and Infectious Diseases, National Institutes of Health.  ... GenVec,s proprietary gorilla adenovirus vectors to deliver a ... in order to create and test a variety ...
Breaking Medicine Technology:Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era 2Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era 3Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era 4Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 2Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 3Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 4Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 5Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 6Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 7GenVec Announces Collaboration with the Laboratory of Malaria Immunology & Vaccinology 2GenVec Announces Collaboration with the Laboratory of Malaria Immunology & Vaccinology 3
... Feb. 16, 2012 Millstone Medical Outsourcing announced today ... CA, and Warsaw, IN.  With new offices positioned in ... will be able to provide customer-specific program development as ... Senior Vice President, will run the San Diego office, ...
... Inc. (PSI), a leading pharmaceutical CRO, announced today that ... oral formulation efforts.  According to Mark Mitchnick, the company,s ... technologies applicable across many dosage forms and drug types.  ... on small molecules of which about 80% fall into ...
Cached Medicine Technology:Millstone Medical Outsourcing Opens Sales Offices in CA, IN 2Particle Sciences Hires Robert Gwozdz to Head Oral Formulation 2
(Date:4/21/2015)... (PRWEB) April 21, 2015 Optimity ... Information Technology advisory firm that helps clients in ... today announced that the Association of Community ... Preferred Vendor. ACAP represents 58 local, not-for-profit, community-affiliated ... than 13 million people primarily enrolled in public ...
(Date:4/21/2015)... 21, 2015 Quark Software Inc. ... new knowledge management solution that enables large enterprises ... policies and procedures. With Quark Procedure Management, corporate ... that is easy to save, search and update, ... risk and compliance issues. Examples of policies and ...
(Date:4/21/2015)... Pittsburgh, PA (PRWEB) April 21, 2015 ... and delayed healing can result. In order to solve ... patent-pending Armor Protective Bandaging. , This improved bandage helps ... It also reduces pain and enhances air exposure. The ... design variations. , The original design was submitted to ...
(Date:4/21/2015)... Ill. (PRWEB) April 21, 2015 The ... the late cosmetic dermatologist Fredric S. Brandt, M.D., by ... Dr. Brandt, an ASDS member since 1982, died earlier ... The funds are designed to provide opportunities for ASDS ... field of cosmetic dermatology that Dr. Brandt held so ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 NOVAtime ... of enterprise Time and Attendance / Workforce Management ... Congress from the American Payroll Association (APA) as ... , The APA has been the nation’s payroll ... workshops, networking opportunities, and recertification credits. Held at ...
Breaking Medicine News(10 mins):Health News:Optimity Advisors Named Preferred Vendor by the Association of Community Affiliated Plans (ACAP) 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 3Health News:ASDS honors the legacy of Dr. Fredric Brandt 2Health News:ASDS honors the legacy of Dr. Fredric Brandt 3Health News:ASDS honors the legacy of Dr. Fredric Brandt 4Health News:NOVAtime Participates in 2015 APA Congress and NetSuite SuiteWorld Conferences in May 2Health News:NOVAtime Participates in 2015 APA Congress and NetSuite SuiteWorld Conferences in May 3
... , Brio Active opens its doors this month, offering a ... its core. , , DENVER, June 19 Brio ... vibration, a relatively new fitness concept in the U.S., with ... strength, flexibility, balance, energy, bone density, and neuromuscular coordination. ...
... Intelligent InSites Announces ... ... World Health Organization declared the H1N1 virus, also commonly referred to as "swine flu", a ... take precautions to limit the spread of the virus from infected patients to healthy patients ...
... , SANTA ROSA, Calif., June 19 The American ... and Drug Administration,s (FDA) action to protect the public ... in connection with that company,s sale of Zicam intranasal ... products have been associated with a number of cases ...
... N.Y., June 19 Kenneth A. May, former CEO of FedEx ... the March of Dimes, it was announced today. , , ... mission, especially our Prematurity Campaign," said Dr. Jennifer L. Howse, President ... leadership as we work towards our goal of giving every baby ...
... Arcadian Health, a leading provider of Medicare Advantage health ... to health care provider groups, hospitals and health plans, ... been elected as the Chairman of the Board of ... the role of Chairman of the Board, filling the ...
... It cut odds for substance abuse, violence by the ... (HealthDay News) -- A school-based prevention program begun in ... violence and early sexual activity, says a U.S. study. ... schools in Hawaii with below-average standardized test scores and ...
Cached Medicine News:Health News:Brio Active Brings Whole Body Vibration Fitness to Cherry Hills Village 2Health News:Real-Time Locating Technology Helps Contain Pandemic Outbreaks 2Health News:Real-Time Locating Technology Helps Contain Pandemic Outbreaks 3Health News:Real-Time Locating Technology Helps Contain Pandemic Outbreaks 4Health News:Homeopathic Pharmacists' Association Highlights the Extraordinary Safety Record of Homeopathic Medicines 2Health News:Arcadian Management Services Names CEO Robert Fahlman as Chairman of the Board 2Health News:Program Helps 1st Graders Stay Safe Long-Term 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: